S'abonner

International incidence of childhood cancer, 2001–10: a population-based registry study - 15/06/17

Doi : 10.1016/S1470-2045(17)30186-9 
Eva Steliarova-Foucher, DrPhD a, , Murielle Colombet, MSc a, Lynn A G Ries, MS b, Florencia Moreno, PhD c, Anastasia Dolya, MSc a, Freddie Bray, PhD a, Peter Hesseling, PhD d, Hee Young Shin, PhD e, Charles A Stiller, MSc f
the

IICC-3 contributors

  Contributors listed in the Supplementary Material
S Bouzbid, M Hamdi-Cherif, A Hablas, E Chirpaz, N Buziba, GC Chesumbai, SS Manraj, D Reynders, HR Wabinga, E Chokunonga, F Moreno, CA Lima, C Asturian Laporte, JC de Oliveira, JA Pontes de Aquino, SM Vargas Gallagher, CJ Uribe, LE Bravo, MC Yepez Chamorro, G Torres Alvarado, YH Galán Alvarez, FC Martinez Reyes, JC Castillo Calvas, M Mendoza Alava, P Cueva Ayala, B Hanchard, A Fajardo-Gutiérrez, DE Zavala Zegarra, E Barrios, C Nikiforuk, R Woods, D Turner, M MacIntyre, A Corriveau, T Navaneelan, C Bertrand, H Stuart-Panko, RJ Wilson, C Kosary, X Shen, J Brockhouse, GA Yee, TC Mitchell, K Snipes, D West, C Rao, S Bolick, RK Rycroft, L Mueller, Y Zheng, K Dosch, H Brown, A Vargas, GM Levin, R Bayakly, C Johnson, T Shen, L Ruppert, CF Lynch, SM Lai, TC Tucker, XC Wu, M Schwenn, K Stern, S Gershman, G Copeland, S Bushhouse, DB Rogers, J Jackson Thompson, D Lemons, S Frederick, JA Harris, B Riddle, A Stroup, C Wiggins, MJ Schymura, LK Giljahn, A Sheikh, S Schubert, W Aldinger, JP Fulton, M Whiteside, L Nogueira, C Sweeney, A Johnson, J Martin, S Farley, D Harrelson, R Malicki, JR Espinoza, BY Hernandez, N Abulfateh, N Wang, RKC Ngan, KB Lingegowda, R Swaminathan, SS Koyande, B Silverman, K Ozasa, S Kanemura, M Soda, I Miyashiro, A Shibata, O Nimri, YJ Won, CH Kim, NS Hong, HS Nam, S Kweon, WC Kim, JS Huh, KW Jung, CI Yoo, A Elbasmy, AV Laudico, MR Lumague, H AlMutlag, R Buasom, S Srisukho, J Tanabodee, S Wiangnon, D Pongnikorn, H Sriplung, O Dirican, S Eser, M Le Hoang, M Hackl, A Zborovskaya, N Dimitrova, Z Valerianova, M Sekerija, P Pavlou, M Dušek, M Mägi, J Clavel, B Lacour, AV Guizard, V Bouvier, X Troussard, AS Woronoff, B Tretarre, M Colonna, F Molinié, S Bara, M Velten, E Marrer, O Ganry, P Grosclaude, P Kaatsch, SR Zeissig, B Holleczek, A Katalinic, Z Jakab, H Birgisson, PM Walsh, L Mangone, F Merletti, M Magoni, L Mangone, S Ferretti, D Serraino, G Spagnoli, M Fusco, M Michiara, R Tumino, F Falcini, F Sensi, F Tisano, S Piffer, F Stracci, G Tagliabue, G Smailyte, D Agius, O Visser, G Ursin, J Didkowska, M Trojanowski, U Wojciechowska, G Forjaz de Lacerda, MA Silva, J Laranja Pontes, A da Costa Miranda, E Kaiserova, M Primic Žakelj, R Peris-Bonet, ML Vicente Raneda, E Almar Marqués, JR Quirós Garcia, M Ramos Monserrat, M Errezola Saizar, A Alemán Herrera, JM Díaz García, R Marcos-Gragera, MJ Sanchez-Perez, E Ardanaz Aicua, J Galceran, A Klint, CE Kuehni, C Bouchardy, F Levi, A Bordoni, I Konzelmann, S Rohrmann, CA Stiller, AT Gavin, DH Brewster, H Phung, S Rushton, S Guthridge, J Aitken, K D’Onise, A Venn, H Farrugian, TJ Threlfall, S Laumond, L Yen Kai Sun, J Hendrix, K Ballantine, M Colombet, A Dolya, E Masuyer, E Steliarova-Foucher

a Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France 
b Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA 
c Paediatric Cancer Registry, National Cancer Institute, Buenos Aires, Argentina 
d Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg Children’s Hospital, Tygerberg, South Africa 
e Seoul National University Children’s Hospital, Institute of Cancer Research, Seoul, South Korea 
f National Cancer Registration and Analysis Service, Public Health England, Oxford, UK 

* Correspondence to: Dr Eva Steliarova-Foucher, Section of Cancer Surveillance, International Agency for Research on Cancer, World Health Organization, Lyon 69372, CEDEX 08, France Section of Cancer Surveillance International Agency for Research on Cancer World Health Organization Lyon CEDEX 08 69372 France

Summary

Background

Cancer is a major cause of death in children worldwide, and the recorded incidence tends to increase with time. Internationally comparable data on childhood cancer incidence in the past two decades are scarce. This study aimed to provide internationally comparable local data on the incidence of childhood cancer to promote research of causes and implementation of childhood cancer control.

Methods

This population-based registry study, devised by the International Agency for Research on Cancer in collaboration with the International Association of Cancer Registries, collected data on all malignancies and non-malignant neoplasms of the CNS diagnosed before age 20 years in populations covered by high-quality cancer registries with complete data for 2001–10. Incidence rates per million person-years for the 0–14 years and 0–19 years age groups were age-adjusted using the world standard population to provide age-standardised incidence rates (WSRs), using the age-specific incidence rates (ASR) for individual age groups (0–4 years, 5–9 years, 10–14 years, and 15–19 years). All rates were reported for 19 geographical areas or ethnicities by sex, age group, and cancer type. The regional WSRs for children aged 0–14 years were compared with comparable data obtained in the 1980s.

Findings

Of 532 invited cancer registries, 153 registries from 62 countries, departments, and territories met quality standards, and contributed data for the entire decade of 2001–10. 385 509 incident cases in children aged 0–19 years occurring in 2·64 billion person-years were included. The overall WSR was 140·6 per million person-years in children aged 0–14 years (based on 284 649 cases), and the most common cancers were leukaemia (WSR 46·4), followed by CNS tumours (WSR 28·2), and lymphomas (WSR 15·2). In children aged 15–19 years (based on 100 860 cases), the ASR was 185·3 per million person-years, the most common being lymphomas (ASR 41·8) and the group of epithelial tumours and melanoma (ASR 39·5). Incidence varied considerably between and within the described regions, and by cancer type, sex, age, and racial and ethnic group. Since the 1980s, the global WSR of registered cancers in children aged 0–14 years has increased from 124·0 (95% CI 123·3–124·7) to 140·6 (140·1–141·1) per million person-years.

Interpretation

This unique global source of childhood cancer incidence will be used for aetiological research and to inform public health policy, potentially contributing towards attaining several targets of the Sustainable Development Goals. The observed geographical, racial and ethnic, age, sex, and temporal variations require constant monitoring and research.

Funding

International Agency for Research on Cancer and the Union for International Cancer Control.

Le texte complet de cet article est disponible en PDF.

Plan


© 2017  World Health Organization. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 18 - N° 6

P. 719-731 - juin 2017 Retour au numéro
Article précédent Article précédent
  • Graphing individual cancer experiences with Cancergraph
  • Emily Jenkins
| Article suivant Article suivant
  • Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial
  • Véronique Diéras, David Miles, Sunil Verma, Mark Pegram, Manfred Welslau, José Baselga, Ian E Krop, Kim Blackwell, Silke Hoersch, Jin Xu, Marjorie Green, Luca Gianni

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.